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SUMMARY
The antimalarial drug meﬂoquine has promising antischistosomal properties killing haematophagous adult schistosomes as
well as schistosomula. Themode of action and involved drug targets ofmeﬂoquine inSchistosomamansoni schistosomula are
unknown. In order to identify meﬂoquine-binding proteins and thus potential drug targets, meﬂoquine aﬃnity
chromatography with S. mansoni schistosomula crude extracts was performed. We found one speciﬁc meﬂoquine-binding
protein that was identiﬁed by mass spectrometry as the glycolytic enzyme enolase (Q27877). Enolase activity assays were
performed on schistosomula crude extracts and on the recombinant enolase Q27877 expressed in Escherichia coli.
In schistosomula crude extracts enolase activity was inhibited by meﬂoquine and by the enolase inhibitor sodium ﬂuoride,
while activity of the recombinant enolase was not aﬀected. In contrast to enolase from crude extracts, recombinant Q27877
did not bind to meﬂoquine-agarose. Using isothermal microcalorimetry, we next investigated the metabolic inhibition
of meﬂoquine and 3 known glycolytic inhibitors in Schistosoma spp., namely sodium ﬂuoride, 3-bromopyruvate and
menadione on schistosomula in the presence or absence of glucose. We found that in the presence of glucose, schistosomula
were less aﬀected by meﬂoquine, sodium ﬂuoride and 3-bromopyruvate, whereas glucose had no protective eﬀect when
schistosomula had been exposed to menadione. These results suggest a potential role of meﬂoquine as an inhibitor of
glycolysis, at least in stages where other targets like haem degradation are not relevant.
Key words: Schistosoma mansoni, aﬃnity chromatography, meﬂoquine, drug target, enolase, metabolic inhibition,
isothermal microcalorimetry, glycolysis.
INTRODUCTION
Antischistosomal chemotherapy is still restricted
to the use of praziquantel. The antimalarial drug
meﬂoquine, a synthetic analogue of quinine has
promising antischistosomal activity in vitro and
in vivo (Keiser et al. 2009, 2010; Xiao et al. 2011).
The mode of action and the target of meﬂoquine
in Schistosoma spp. are, however, not known.
Knowledge of the drug target might, however, aid
in the design and discovery of novel antischistosomal
drugs (Renslo and McKerrow, 2006; Sleno and
Emili, 2008).
There is good evidence that in Plasmodium spp.
meﬂoquine interferes with haemoglobin degradation.
Toxic haem is released when the parasite feeds
on haemoglobin. The haem is rapidly oxidized to
haemin and subsequently converted to haemozoin.
In the presence of meﬂoquine the conversion of free
haem to haemozoin is inhibited. As a consequence,
toxic haem and haemin complexes accumulate and
kill the parasite (Dorn et al. 1998; Zhang et al. 1999;
Pasternack et al. 2010).
Schistosomes feed on blood and haem is detoxiﬁed
into large insoluble crystals identical to Plasmodium
haemozoin (Oliveira et al. 2000). Therefore, a similar
mode of action of meﬂoquine in both parasites is
probable. A recently conducted in vitro study
suggests that meﬂoquine interferes with the haem
detoxiﬁcation pathway in Schistosoma mansoni, since
a more pronounced activity of the drug was observed
against S. mansoni in the presence of haemin
(Manneck et al. 2011a). However, meﬂoquine also
shows high in vitro activities on 1-day-old S. mansoni
schistosomula and on adult schistosomes without
addition of haemin or red blood cells. In fact, RNAi
studies have shown that schistosomula show an
extensive uptake of exogenous material into the gut
immediately after transformation of cercariae into
schistosomula. Haemoglobin-derived pigment is
present in the gut of 2-day-old schistosomula, but
there is no evidence for blood uptake at earlier time-
points (Stefanic et al. 2010). This suggests that the
drug may have targets independent of haemoglobin
digestion.
The purpose of the present work was to identify
targets for meﬂoquine in 1-day-old, most likely
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non-haem feeding S. mansoni schistosomula. Schi-
stosomula can easily be produced by mechanical
transformation of cercariae obtained from infected
Biomphalaria glabrata snails (Keiser, 2010).
Here, we present a meﬂoquine aﬃnity chromato-
graphy study (Müller et al. 2008) in order to identify
meﬂoquine-binding proteins in schistosomula
and report on the identiﬁcation of S. mansoni enolase
(EC 4.2.1.11; Q27877) as a major meﬂoquine-
binding protein. Enolase is the enzyme catalysing
the conversion of phosphoglycerate to phosphoenol-
pyruvate in the Embden-Meyerhoﬀ-Parnas pathway
of glycolysis. These investigations were complemen-
ted by functional enolase assays and by isothermal
microcalorimetry studies (Manneck et al. 2011b).
MATERIALS AND METHODS
Parasite
The S. mansoni life cycle is maintained at the
Swiss Tropical and Public Health Institute in
Basel, Switzerland. The intermediate host snails
(Biomphalaria glabrata) were exposed to light for
approximately 3 h around noon and subsequently
cercariae of S. mansoni were harvested.
Chemicals and drugs
Meﬂoquine hydrochloride (414·81 g/mol) was
kindly provided by Mepha Pharma AG (Aesch,
Switzerland). Penicillin/streptomycin solution and
M199 culture medium are products from Gibco/
Invitrogen (Carlsbad, USA) obtained by Lubio
Science GmbH (Lucerne, Switzerland). If not
otherwise stated, all chemical reagents were from
Sigma-AldrichChemieGmbH(Buchs,Switzerland).
Drug stock solutions were prepared in DMSO or
water and stored at −20 °C.
Preparation of S. mansoni schistosomula
Cercariae of S. mansoni were mechanically trans-
formed into schistosomula by repeat vortexing as
described previously (Keiser, 2010; Manneck et al.
2010). The schistosomula were then kept in M199
culture medium supplemented with 5% heat-
inactivated foetal calf serum and 100U/ml penicillin
and 100 μg/ml streptomycin at 37 °C in an atmosphere
of 5% CO2 for a minimum of 3–12 h, to assure
that transformation into the schistosomular stage
was completed. Afterwards the parasite suspension
was centrifuged (8000 g, 5 min, room temperature),
washed twice with phosphate-buﬀered saline (PBS),
and followed by another centrifugation step. The
pellet was stored at −20 °C.
Isothermal microcalorimetry
A 48-channel isothermal microcalorimeter (Model
TAM 48, TA Instruments, New Castle, Delaware,
USA) was used to measure the production of heat by
S. mansoni schistosomula incubated with 1 of 3
diﬀerent glycolytic inhibitors, namely ﬂuoride (1 and
20mM), menadione (50 μM) and 3-bromopyruvate
(0·5mM) or meﬂoquine (24 and 48 μM; 10 and
20mg/l). Untreated schistosomula and dead parasites
served as controls. Parasites were killed with ethanol
and death was conﬁrmed by microscopical evaluation
as described previously (Manneck et al. 2011a). Pure
medium represented the background control. The
calorimeter and the injection system were described
in detail in a previous publication (Manneck et al.
2011b). Brieﬂy, glass ampoules were ﬁlled with
1800 μl of culture medium M199 with or without
glucose supplementation (20 mM). Then 100 μl of
schistosomula suspension containing approximately
600 schistosomula were added. Ampoules were
placed into the measuring channels and when a stable
signal was obtained (approximately after 12 h), 100 μl
of medium containing diﬀerent volumes of drug
stock solution or ofDMSO (as a solvent control) were
injected into the ampoules. Heat-ﬂows with 1 data
point per 10min were recorded for 96 h at maximum.
Heat-ﬂow curves of treated and untreated parasites
were examined before and after addition of drug.
Heat-production of schistosomula treated with the
compound alone or in the presence of glucose were
compared 24 h after drug addition. All samples were
analysed in triplicate.
Preparation of schistosomula crude extracts
For protein extraction, frozen schistosomula pellets
were re-suspended in ice-cold extraction buﬀer
consisting of PBS, 1% Triton-X-100, and a protease
inhibitor cocktail (Halt, Thermo Scientiﬁc,
Rockland, IL, USA). Suspensions were vortexed
thoroughly following repeated freezing on dry ice-
isopropanol and thawing. After 3 cycles of freezing
and thawing, the suspension was centrifuged
(15 200 g, 10 min, 4 °C). Supernatants were collected,
and extraction of pellets was repeated twice. The
supernatants were combined and subjected to enolase
assays or to meﬂoquine-agarose aﬃnity chromato-
graphy. For aﬃnity chromatography, approximately
8·5×105 parasites (10 transformation procedures
with 70–90 intermediate host snails each) were
extracted in 3×1ml of extraction buﬀer. For enolase
assays less parasites (about 4×105 schistosomula) and
accordingly modiﬁed extraction volumes were used.
Aﬃnity chromatography with S. mansoni
schistosomula crude extracts on meﬂoquine-epoxy
agarose
In order to produce meﬂoquine-agarose, 0·3 g lyo-
philized epoxy-agarose with a C-12-spacer was
suspended in 15ml of H2O and centrifuged at 300 g
for 5 min. Washes in water were repeated twice, and
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the suspension was washed once in coupling buﬀer
(NaHCO3 0·1M, pH 9·5). After the last wash, epoxy-
agarose was suspended in 2ml of coupling buﬀer.
Twenty mg meﬂoquine were dissolved in 2ml of
dimethyl-formamide and added to the agarose. The
mixture was incubated for 3 days at 37 °C under slow
but continuous shaking in order to allow coupling of
the epoxy group to meﬂoquine via the OH- group of
the piperidine-2-yl-methanol part of the molecule.
For the negative control a mock columnwas prepared
by blocking a column with ethanol-amine only
(Müller et al. 2008). Prior to the runs, both columns
(bed volumes ca. 1 ml each) were combined in
a tandem (mock column ﬁrst, then meﬂoquine
column) and washed with 50ml of PBS equilibrated
at 20 °C. Then 3ml of schistosomula crude extract
was loaded onto the column tandem at a ﬂow rate of
0·25ml/min. The columns were washed with PBS
until a ﬂat baseline was detected (more than 10
column volumes). The columns were separated, and
proteins binding to the columns were eluted with
1mM meﬂoquine in PBS followed by elution with a
pH shift (glycine Cl− 100mM, pH 2·9) in order to
remove non-speciﬁcally bound proteins. Moreover,
fractions were taken before elution with meﬂoquine
(pre-meﬂoquine) and following a pH shift (pre-pH
shift). Sizes of these fractions ranged between 3 and
5ml. Aliquots from each fraction (200 μl) and from
the crude extract (50 μl) were taken and analysed by
SDS-PAGE. SDS-PAGE and silver staining were
performed as summarized in a recent publication
(Müller et al. 2008).
The protein identiﬁed in the meﬂoquine eluate
only was then further analysed bymass spectrometry.
For protein sequencing by mass spectrometry,
protein was prepared (Müller et al. 2008) and
sequenced by the Proteomics Core Facility, Faculty
of Medicine, University of Geneva, Switzerland.
Cloning and heterologous expression of recombinant
S. mansoni enolase
Cloning, heterologous expression and His-tag puriﬁ-
cation of recombinant enolase were carried out as
described (Müller et al. 2008). Brieﬂy, in order to
clone enolase into the His-tag-expression vector
pET151 directional TOPO (Invitrogen, Carlsbad,
CA), the primers pENOfor (CACCATGTCCAT-
TTTAACGATCCAC) and pENOrev (TTATA-
CTTTGGGATGGCGGAAG) were created for
the ampliﬁcation of a 1260 base pair product
encoding the enolase (Q27877) polypeptide with 4
additional bases at the 5′end allowing directional
cloning (MWG Biotech, Ebersberg, Germany).
cDNA was created from adult S. mansoni following
a protocol by Lochmatter et al. (2009) and PCR was
performed using Phusion Polymerase and the ap-
propriate protocol (Phusion TM DNA Polymerase,
High Fidelity PCR KIT, Finnzymes). The resulting
product was cloned into pET151 TOPO vector and
transformed into E. coli TOP 10 cells (Invitrogen).
Heterologous expression of enolase in positive
transformants of Escherichia coli (BL21 Star)
and subsequent his-tag puriﬁcation of recombinant
enolase was performed as previously described
(Müller et al. 2008). Puriﬁed protein was stored in
50% glycerol at −20 °C.
Enolase assay
Enolase activity was determined using an enzymatic
assay coupled to pyruvate kinase and L-lactate
dehydrogenase by measuring the conversion of
NADH to NAD by the latter enzyme according to
a protocol of Sigma-Aldrich. The assay was per-
formed in a 96-well-plate containing a total volume of
250 μl in each well and 80mM triethanolamine buﬀer
(pH 7·4), 0·12mM ß-NADH, 25mM magnesium
sulfate, 100mM potassium chloride solution,
1·3 mM ADP, 7U/ml pyruvate kinase, 10U/ml of
lactate dehydrogenase and enolase (crude extracts or
recombinant, 2–5 μl). The reaction was initiated
by adding the enolase substrate 2-phosphoglycerate
(0–1·8 mM). Blanks without enolase and blanks
without substrate served as controls.
For inhibition studies, meﬂoquine and sodium
ﬂuoride were added as indicated in Fig. 3 of the
results section (24–240 μM). All samples were
assessed in triplicate. The decrease of absorbance
of NADH was recorded for 20min at 340 nm
by continuous photometric rate determination
(VersaMax™ Absorbance Microplate Reader,
Molecular Devices, Sunnyvale, California, USA).
Eﬀects of meﬂoquine on pyruvate kinase and lactate
dehydrogenase were monitored by adding phospho-
enolpyruvate (ﬁnal concentration of 1·8 mM) instead
of enolase and 2-phosphoglycerate to the reaction
mix.
Statistics
Pairwise t-tests were performed using the StatsDirect
statistical software package (version 2.7.2.,
StatsDirect Ltd; Cheshire, UK). Km and Vmax values
were determined after regression analysis by the
corresponding software tool contained in the Excel
software package (Microsoft, Seattle, Washington,
USA).
RESULTS
Enolase is a major meﬂoquine-binding protein in
S. mansoni schistosomula
Since meﬂoquine was found to aﬀect the non-
haematophagous schistosomula (Manneck et al.
2010) we aimed to identify the cellular target of this
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drug in schistosomula. Meﬂoquine was coupled to
epoxy-agarose, a mock-column was prepared, and
aﬃnity chromatography was performed with schis-
tosomula crude extracts on both columns mounted in
tandem. Both columns were washed and separately
eluted with meﬂoquine or a low-pH buﬀer. The
elution with low pH of both columns yielded
bands of ca. 40 and 30 kDa. These bands were also
present to various extents in meﬂoquine elutions.
In addition, only elution with meﬂoquine of the
meﬂoquine-column yielded a band of ca. 50 kDa
(Fig. 1A, rectangle). This band was subjected to mass
spectrometry analysis. Eight peptides aligned with
100% protein probability to S. mansoni enolase
Q27877 (identical to AAC46884, AAC46886,
CBN61518.1) and to S. mansoni enolase C4Q3S7
(identical to XP_002573848.1, CAZ30081.1) with
23% coverage of the sequence (Fig. 1B). C4Q3S7
diﬀered in 2 amino acids only from Q27877, namely
an isoleucine instead of a threonine in position 52 and
a phenylalanine instead of a tyrosine in position 93.
Q27877 was identiﬁed through an analysis of trans-
spliced mRNAs (Davis et al. 1995), C4Q3S7 via the
genomic sequencing eﬀort (Berriman et al. 2009).
Analysis by BLAST (Altschul et al. 1997) revealed
that the coding sequences for both proteins were
identical (data not shown). One peptide aligned
also to enolases from S. japonicum (P33676) and
F. hepatica (Q27655), 3 aligned with the S. japonicum
enolase only, 4 were unique to S. mansoni. The
protein with the highest similarity in humans is
alpha-enolase (P06733; Fig. 1B).
Enolase activity from schistosomula crude extract is
inhibited by meﬂoquine
Enolase activity in parasite crude extracts was
inhibited by meﬂoquine in a concentration-
dependent manner at 24 μM and above. At 240 μM,
both meﬂoquine and sodium ﬂuoride, a well-known
enolase inhibitor (Warburg and Christian, 1941),
nearly completely inhibited enolase activity in crude
extracts (Fig. 2). The inhibition by meﬂoquine was
not due to inhibition eﬀects on the coupled reactions
catalysed by pyruvate kinase and lactate dehydro-
genase. This was shown by control assays where the
product of the reaction catalysed by enolase, namely
Fig. 1. (A) SDS-PAGE of aﬃnity chromatography eluates of Schistosoma mansoni schistosomula extracts. Eluates were
obtained by meﬂoquine-agarose aﬃnity chromatography (MQ-column; lanes 1–4) and by an ethanolamine coupled
mock column (negative control; lanes 5–8). Marker (M), crude extract (CE), Wash plus pre-meﬂoquine (1 and 5),
eluates with 1mM meﬂoquine (2 and 6 and 3 and 7), pH-shift with 0·1 M glycine at pH 2·9 (4 and 8). Bands were
visualized by silver staining. (B) Protein sequence of S. mansoni enolase Q27877 (SCHMA) and alignment with other
enolases, namely P33676 from S. japonicum (SCHJA), Q27655 from Fasciola hepatica (FASHE) and P06733 from
human (HUMAN). Peptides identiﬁed by mass spectrometry are highlighted in grey.
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phosphoenol-pyruvate, was added to the reactionmix
instead of enolase and the substrate 2-phosphoglyce-
rate. Activities of the coupled reactions performed
without meﬂoquine (Control, 60·6 ΔmA340/min
±3·5) or with 240 μM meﬂoquine (59·3ΔmA340/min
±4·6) were identical.
Subsequently, Q27877 was over-expressed as a
His-Tag protein in E. coli and aﬃnity puriﬁed under
non-denaturing conditions (Fig. 3A). The recombi-
nant protein had enolase activity, but was not
inhibited, either by ﬂuoride or by meﬂoquine at
240 μM (Fig. 3B). In order to see whether the
recombinant enzyme had the same catalytic proper-
ties as the enolase activity in crude extracts, we
performed enolase assays with both enzymes at
various substrate concentrations and determined
Km and Vmax values according to Lineweaver-
Burke. Enolase from crude extracts had nearly
1 magnitude higher Km and about 5 times lower
Vmax values than the recombinant enzyme (Table 1).
Moreover, we performed a pull-down assay on
meﬂoquine agarose with the recombinant enolase.
The protein was detected quantitatively in the ﬂow-
through, hence the recombinant protein did not bind
to the column (Fig. 3C).
Glucose interferes with the antischistosomal activity
of meﬂoquine
Based on previously published results on metabolic
inhibition of schistosomula by meﬂoquine, we
compared the eﬀect of meﬂoquine to compounds
well known for interfering with glycolysis, namely
sodium ﬂuoride (Warburg and Christian, 1941) and
3-bromopyruvate (Pelicano et al. 2006).We hypothe-
sized that a supplementation of the medium
with glucose may counteract inhibition by these
compounds. Additional glucose would oﬀer more
substrate for each reaction during glycolysis, increase
the rate of glycolysis and might decrease the
inhibitory eﬀect of the tested glycolytic inhibitors
and of meﬂoquine. As a control, we included
menadione (Bueding, 1950) interfering with glycoly-
sis via induction of oxidative stress (Verrax et al.
2006).
Figure 4 illustrates the relative heat production
(metabolic activity of untreated control worms in the
absence of glucose was set to 100%) of schistosomula
incubated with the 4 tested compounds in the
presence or absence of glucose (0 and 20mM) 24 h
post-incubation. The addition of glucose caused no
signiﬁcant increase as compared to the control group.
After incubation with 24 μM meﬂoquine in glucose-
free medium, metabolic activity of schistosomula
dropped to nearly one ﬁfth of the control values.
Schistosomula incubated with 20mM glucose
showed a signiﬁcantly higher metabolic activity
after exposure to meﬂoquine as compared to schisto-
somula incubated in plain medium. The same eﬀect
was seen for schistosomula incubated with 48 μM
meﬂoquine. By 24 h post-incubation, metabolic
activity of parasites incubated in glucose-free med-
ium had decreased to less than 20% compared to
control values, whereas worms exposed to meﬂo-
quine incubated in medium containing glucose had a
signiﬁcantly higher activity. When schistosomula
were incubated with a lower concentration of
10mM glucose (data not shown) again a signiﬁcantly
higher heat-ﬂow after exposure to meﬂoquine was
seen, when compared to schistosomula incubated
in medium without glucose. The eﬀects of higher
meﬂoquine concentrations could not be evaluated
since these doses resulted in a rapid decrease of
metabolic activity of schistosomula, which was too
fast to be recordable by our system (Manneck et al.
2011b).
The addition of sodium ﬂuoride caused a
concentration-dependent decrease of the heat-ﬂow.
Incubation with 20mM sodium ﬂuoride resulted in
death of all schistosomula. In the presence of 20mM
sodium ﬂuoride plus glucose metabolic activity was
still detectable. Both parasites incubated with and
without additional glucose had similar metabolic
activities 24 h after incubation with 50 μM 3-
bromopyruvate (data not shown). In the presence
of 0·5 mM 3-bromopyruvate metabolic activity was
nearly at background levels. In the presence of
glucose and 0·5 mM 3-bromopyruvate metabolic
activity was detectable at nearly 10% of the control
levels. Finally, menadione (50 μM) killed schistoso-
mula 24 h post-incubation regardless of glucose
supplementation.
DISCUSSION
Isothermal microcalorimetry, which measures the
heat produced by microorganisms has proven to be a
Fig. 2. Meﬂoquine inhibits enolase activity in
Schistosoma mansoni crude extracts. Enolase assays were
performed with S. mansoni schistosomula crude extracts
in the presence of diﬀerent concentrations of meﬂoquine
(MQ 0–240 μM) or sodium ﬂuoride as a positive control
for inhibition (NaF 240 μM). Data are expressed as the
decrease of absorption at 340 nm over time.
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suitable method to evaluate the activity of antischis-
tosomal compounds (Manneck et al. 2011b). Energy
acquisition in schistosomes is provided mainly via
glycolysis (Bueding, 1950; Van den Bossche, 1985;
Yang et al. 2010). Compounds interfering with
glycolysis thus rapidly block muscular contraction
and heat development. We have investigated a series
of compounds directly interfering with glycolysis,
namely sodium ﬂuoride, 3-bromopyruvate, and
menadione on schistosomula using micro-
calorimetry. Sodium ﬂuoride is a well-characterized
inhibitor of enolase, the enzyme catalysing the
A
B
C
Fig. 3. Recombinant enolase Q27877 is not inhibited either by ﬂuoride or by meﬂoquine. (A) SDS-PAGE of his-tag
puriﬁed recombinant enolase. Marker (M), crude extract (CE), ﬂow through (FT), eluates (1–3). (B) Enolase activity
of recombinant Q27877 in the presence of 240 μMmeﬂoquine (MQ 240) or 240 μM sodium ﬂuoride (NaF 240).
(C) SDS-PAGE of meﬂoquine agarose aﬃnity chromatography of recombinant enolase Q27877. Crude extract (CE),
ﬂow-through (1), wash (2), pre-meﬂoquine (3), meﬂoquine (4), meﬂoquine pre pH-shift (5), pH-shift (0·1M glycine,
pH 2·9) (6). Bands were visualized by silver staining.
Table 1. Kinetic parameters of enolase activity
from Schistosoma mansoni schistosomula crude
extracts and of recombinant enolase Q27877
(To determine Km and Vmax values, enolase reactions were
performed with substrate concentrations ranging from 0·1
to 1·8 mM.The reciprocals of the resulting reaction rate (vi)
values and the substrate concentrations were plotted and
Km and Vmax values and the corresponding errors were
calculated by regression analysis.)
Parameter Crude extract Recombinant
Km (mM) 3·22±0·21 0·21±0·05
Vmax (mkat/mg prot) 95·2±26·2 485·2±81·5 Fig. 4. Heat-ﬂow of Schistosoma mansoni schistosomula
24 h post-incubation with 24 μM (MQ 24) and 48 μM
meﬂoquine (MQ 48), 1 mM or 20mM sodium ﬂuoride
(NaF 1, NaF 20), 0·5 mM 3-bromopyruvate (3-BP),
or with 50 μM menadione (Men) in the absence of
glucose (Control) or with glucose (20mM Glc). Mean
values±S.E. are indicated for 4 replicates. Values with
signiﬁcant diﬀerences (t-tests; P< 0·05) between samples
with and without additional glucose are labelled with
asterisks.
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conversion of phosphoglycerate to phosphopyruvate
(Warburg and Christian, 1941). However, sodium
ﬂuoride is not selective to enolase and inhibits a
variety of other enzymes such as phosphatases or
ATPases. Therefore, the reduction of glucose con-
sumption in schistosomula may also be due to eﬀects
of sodium ﬂuoride on other metabolic pathways.
In adult schistosomes, sodium ﬂuoride reduces the
consumption of glucose and the production of lactate
(Bueding, 1950). Menadione is a naphthoquinone
with structural similarities to meﬂoquine. Similar to
sodium ﬂuoride, it reduces glucose consumption and
lactate production in adult schistosomes (Bueding,
1950), but most likely not by an inhibition of
glycolysis but instead by an induction of oxidative
stress (Verrax et al. 2006). 3-bromopyruvate inhibits
hexokinase in the glycolytic pathway and decreases
the ATP content in cells by inhibition of ATP
production and depletion of cellular ATP. Due to its
cytotoxic activity against cancer cells, pre-clinical
trials have been launched to conﬁrm its activity
for anticancer treatment (Pelicano et al. 2006). To
our knowledge, the antischistosomal activity of
3-bromopyruvate has not been described so far.
Our microcalorimetric studies reveal that simul-
taneous addition of glucose attenuates the metabolic
inhibition by sodium ﬂuoride, 3-bromopyruvate and
meﬂoquine, but not by menadione. Note that, in the
case of sodium ﬂuoride, the eﬀective concentration is
very high (above 1mM), which is most likely due to a
reduced uptake of this compound by schistosomula.
This phenomenon has also been described for adult
schistosomes with at least 20mM sodium ﬂuoride
being necessary to inhibit glucose utilization in
the parasites by 50% (Bueding, 1950). Our ﬁndings
suggest that meﬂoquine directly interferes with
glycolysis similar to the two inhibitors of glycolytic
enzymes rather than acting indirectly as menadione.
This assumption is corroborated by biochemical
data.
Using aﬃnity chromatography followed by mass
spectrometry, we have identiﬁed the glycolytic
enzyme enolase as a major meﬂoquine-binding
protein in S. mansoni schistosomula. Enolase activity
in schistosomula crude extracts is inhibited by
meﬂoquine in a similar concentration range as by
sodium ﬂuoride. The recombinant enolase Q27877
is, however, not inhibited by either meﬂoquine or
sodium ﬂuoride. Moreover, the recombinant enolase
has diﬀerent kinetic parameters from the activity in
crude extracts.
At ﬁrst glance, these results suggest that meﬂo-
quine may inhibit an enolase isoform other than
our recombinant Q27877. Mammals have 3 enolase
isoforms, alpha, beta and gamma with multiple
functions beside glycolysis (Pancholi, 2001) and for
S. mansoni to date 2 isoforms of enolase, namely
Q27877 and C4Q3S7, are listed in genomic data-
bases. However, although these 2 isoforms are
provided in genomic databases, it is likely that
enolases other than Q27877 do not exist in
S. mansoni. The small diﬀerences between Q27877
and C4Q3S7, the protein derived from the genomic
sequencing eﬀort, are most likely due to errors,
because the corresponding coding sequences are
identical. A BLAST analysis showed that Q27877
Fig. 5. Scheme summarizing glycolysis in Schistosoma and targets for inhibitors (in rectangles) as used in the present
study. A structural formula of meﬂoquine is shown.
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has 75% identity to human alpha-enolase, 72% to
beta-enolase, and 71% to gamma-enolase and may
thus fulﬁl – to a certain extent – the functional re-
quirements for all classes in mammals.
More likely, enolase from crude extracts has been
subjected to post-translational modiﬁcations and/or
interacted with other proteins present in its natural
cellular environment resulting in catalytic properties
diﬀering from the recombinant enzyme. For example,
in mammalian cells such as human muscle ﬁbres,
enolases may be phosphorylated (Hojlund et al.
2009). The functional implication of this phos-
phorylation is unknown so far. In yeast, enolase is
bound to vacuoles (Decker and Wickner, 2006) and
may be part of a large macromolecular complex
associated with mitochondria (Brandina et al. 2006).
In Plasmodium, enolase has been described to have
undergone post-translational modiﬁcations that are
associated to diﬀerent subcellular fractions (Pal-
Bhowmick et al. 2007). Taken together, these results
indicate that a native enolase may be diﬀerent from
the recombinant enolase produced in E. coli. Results
obtained with the latter may thus not reﬂect the
original situation.
Moreover, there is increasing evidence that in
S. bovis (Ramajo-Hernandez et al. 2007) and
S. japonicum (Yang et al. 2010) enolase is localized
not only intracellularly but also at the cell surface.
The role of this localization is unclear, but extra-
cellular enolase may be involved in the interaction
with host proteins such as plasminogen or the
immune system (Pancholi, 2001). It is possible that
an extracellular, extensively modiﬁed enolase is the
target for meﬂoquine. In S. japonicum, enolase is
expressed in all developmental stages, but has higher
expression levels in schistosomula than in adult
worms suggesting that enolase is critical for growth,
migration and adaption of the young schistosomes
(Yang et al. 2010).
Overall, our results suggest, that in S. mansoni
schistosomula, meﬂoquine inhibits enolase resulting
in an interference with glycolysis and/or in debilitat-
ing the parasite via an unknown mechanism in the
case of extracellular enolase. Since meﬂoquine has
3 ﬂuorine residues, it is possible that it blocks enolase
at the same site as ﬂuoride ions as suggested in the
scheme presented in Fig. 5. Fluoride forms a complex
with magnesium and phosphate at the active site
(Bunick and Kashket, 1982; Qin et al. 2006). There
is, however, a non-deniable discrepancy between
the concentrations of meﬂoquine inhibiting enolase
activity in crude extracts and the nearly 1 magnitude
lower concentrations needed for metabolic inhibition
measured by microcalorimetry and by drug sensi-
tivity assays (Manneck et al. 2011b). This suggests the
existence of other molecular targets for meﬂoquine.
Further work should focus on this aspect as well as on
the role of enolase in themode of action ofmeﬂoquine
in Schistosoma spp.
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